Electromedical Products International, Inc. Unclaimed

Provides rapid, safe, and effective treatment for anxiety, insomnia, and pain.

Provides a potent research platform for non-invasive brain stimulation technologies.

Provides rapid, personalized relief from Major Depressive Disorder symptoms through innovative brain stimulation.

Academic Medical Centers And Research Institutions

Research-focused hospitals and universities pursuing neuromodulation trials.

Private Mental Health And Sleep Clinics

Outpatient clinics seeking drug-free neuromodulation for anxiety and insomnia.

Pain Management Clinics

Clinics focusing on chronic pain with non-drug options.

Neuromodulation Research Laboratories And Clinical Trial Partners

Research labs and CROs advancing neuromodulation research and multi-site trials.

Devices delivering cranial electrotherapy stimulation (CES) for self-administered treatment of anxiety and insomnia; available OTC in some markets and by prescription in others.

Portable microcurrent electrical therapy (MET) systems and electrode accessories for non-opioid management of acute and chronic pain in outpatient and home settings.

Personalized closed-loop transcranial alternating current stimulation (tACS) systems intended to augment standard care and provide rapid symptom relief for adults with major depressive disorder; may include devices with regulatory breakthrough designations.

High-powered, portable platforms that deliver tACS, tDCS and custom waveforms with double-blind capable study management for clinical trials and neuroscience research.

Alpha-Stim

Alpha-Stim is a drug-free, non-invasive medical device that delivers cranial electrotherapy stimulation (CES) to treat anxiety and insomnia and microcurrent electrical therapy (MET) to relieve pain. It is FDA-cleared and available over the counter in many countries; in the US, a prescription is required. Alpha-Stim includes the functionalities of Alpha-Stim M and Alpha-Stim AID, offering a comprehensive therapeutic solution for both pain and mental health issues, complemented by the AS-Trode Silver Electrode Pads for enhanced pain management.

• Delivers Effective CES
  Targets brain activity associated with anxiety and insomnia through cranial electrotherapy stimulation.
• Offers Safe Treatment
  Provides effective treatment options without the risks associated with pharmaceuticals.
• Ensures Regulatory Compliance
  Backed by FDA approval, ensuring safety and effectiveness in treatment.
• Utilizes Advanced Waveform Technology
  Employs a proprietary waveform that enhances treatment efficacy by stimulating brain activity.
• Customizes Therapy Sessions
  Enhances treatment outcomes by tailoring the neurostimulation to individual patient needs and responses.
• Addresses Multiple Health Concerns
  Effectively targets pain relief, anxiety management, and insomnia treatment, promoting overall wellness.
• Achieves Targeted Pain Relief
  Effectively reduces pain by delivering targeted microcurrents directly to affected areas.
• Accessible Worldwide
  Readily available for purchase in various markets, facilitating widespread access to effective therapy.
• Enhances Treatment Options
  Allows for effective treatment of acute, chronic, and post-traumatic pain through innovative AS-Trode silver electrode pads.

XCSITE-RD

XCSITE-RD is a non-invasive brain stimulation research platform capable of delivering high-powered tACS, tDCS, and custom waveform stimulation; portable and easy to use, with double-blind capable software featuring active-sham and multiple study management.

• Enhances Study Validity
  The double-blind capable software increases research reliability by minimizing bias through active-sham controls.
• Targets Brain Activity Precisely
  Offers various stimulation types to target specific brain activities, enhancing treatment personalization and effectiveness.
• Facilitates Research Anywhere
  The lightweight and user-friendly design allows researchers to conduct studies in diverse settings without complicated setups.

Closed-Loop tACS Device

Pulvinar Neuro's Closed-Loop Transcranial Alternating Current Stimulation (tACS) device is designed to treat Major Depressive Disorder. It provides personalized brain stimulation based on real-time brain activity and aims to deliver rapid relief, as part of a drug-free neuromodulation approach.

• Accelerates Access to Patients
  The designation recognizes the device's potential to significantly improve treatment for Major Depressive Disorder, facilitating quicker availability for patients.
• Adapts to Brain Needs
  Utilizes real-time data to customize stimulation, targeting specific disruptions related to depressive symptoms for greater efficacy.
• Achieves Quick Recovery
  Clinical trials show significant symptom reduction in patients, with many reporting freedom from depressive symptoms shortly after treatment.
• Enhances Treatment Efficacy
  Utilized as an addition to standard therapy, improving treatment outcomes for patients with Major Depressive Disorder.